about
An allosteric enhancer of M₄ muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaineCommon variants conferring risk of schizophreniaAntipsychotic-like effect of the muscarinic acetylcholine receptor agonist BuTAC in non-human primatesNeuropeptide Y infusion into the shell region of the rat nucleus accumbens increases extracellular levels of dopaminePsychiatric disease as a risk factor in fast-track hip and knee replacementIncreased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice.Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation.Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in ratsAntipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials.The preferential dopamine D3 receptor agonist cis-8-OH-PBZI induces limbic Fos expression in rat brain.Behavioral and neurochemical effects of the preferential dopamine D3 receptor agonist cis-8-OH-PBZI.Quetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trialAcute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis.Antipsychotic treatment of schizotypy and schizotypal personality disorder: a systematic review.Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case-control studyMuscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse and Parkinson's DiseaseThe glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice.Muscarinic receptor M4 positive allosteric modulators attenuate central effects of cocaine.Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels.Early nonresponse determined by the clinical global impressions scale predicts poorer outcomes in youth with schizophrenia spectrum disorders naturalistically treated with second-generation antipsychoticsIncreased amphetamine-induced locomotor activity, sensitization, and accumbal dopamine release in M5 muscarinic receptor knockout mice.Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial.Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management.Corrected QT changes during antipsychotic treatment of children and adolescents: a systematic review and meta-analysis of clinical trials.Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial.Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial.Treatment of adult patients with schizophrenia and complex mental health needs - A national clinical guideline.Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.Clinical Characteristics and Predictors of Outcome of Schizophrenia-Spectrum Psychosis in Children and Adolescents: A Systematic Review.Psychopharmacologic treatment and blood transfusion in fast-track total hip and knee arthroplasty.Enhanced self-administration of alcohol in muscarinic acetylcholine M4 receptor knockout mice.The relationship between self-reported childhood adversities, adulthood psychopathology and psychological stress markers in patients with schizophrenia.Involvement of a subpopulation of neuronal M4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M1/M4 preferring muscarinic receptor agonist xanomeline.Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor.Current issues in Danish psychiatry.Alcohol consumption among patients with diabetes: a survey-based cross-sectional study of Danish adults with diabetes.Halothane anesthesia enhances the effect of dopamine uptake inhibition on interstitial levels of striatal dopamine.Phenobarbital versus diazepam for delirium tremens--a retrospective study.Increased dopaminergic activity in socially isolated rats: an electrophysiological study.Stereological brain volume changes in post-weaned socially isolated rats.
P50
Q24608616-C704FEC2-447F-4D35-BCBC-A797A0727A24Q24614376-53B4DA1B-8704-4EA5-A531-4CED0DD2CF07Q28546449-7296BEAD-1E94-4458-88DC-FD466B5764A8Q28577357-0DCD648A-5DA1-4942-AD7F-06C018750159Q30251885-55A49D2D-A01E-4BC7-AF50-03B5FBF5CA3BQ30566770-54558911-946B-434D-81CC-F72E90816000Q33714879-630CC55E-D249-4001-923A-B088089E8EA6Q33748306-E2C90198-4CF1-45AA-ACB9-9D36EFB6DAB3Q34327978-3306DECD-68BC-4DD7-9974-BB2563A67852Q34457220-D52AF840-A5B9-44EF-AB8D-7C85FFBBAE14Q34464626-C49A5406-B42D-411E-98D2-AF60B5868878Q34486230-35108B0D-8225-4CCE-ABFE-8C04C07FD608Q34551661-8B76CEDA-6128-4F8F-A713-0BC58CFF5F02Q34681173-3035A4E4-ECD3-45B3-824B-594BC3FF8E43Q35379970-485AD0F7-7F17-449A-9AA0-69802D2FF0B3Q35789730-F00424DE-3DBB-4F71-B9B7-E40B046A6F00Q36343957-52CE7870-3256-4085-A20B-9C7D2265B67AQ36381393-FD3CBCBD-76E3-4C59-8A64-C7C180864564Q37349843-4B9DA0DC-7B89-4AE4-9FE2-E21D1BB8F302Q37409087-6CB18BCE-6B70-43EF-B1AE-8A3D637679B4Q37539911-EF3A84FC-6B6A-445E-BBB9-8587256BB357Q37684797-32D8B183-8790-4B8E-A2F2-3AC1F9F17E90Q38197159-4C03369B-791E-460D-9F51-9ADC5A9087EAQ38294265-8AA4BBB7-583F-4231-8BBD-CDA0372E7A9AQ38375731-E28405B5-8530-4A11-AF3D-21775ED21AA4Q38382180-68517D6E-2B4D-4A9C-91A0-E0D300273CA7Q38578316-EEEAE875-200B-46B0-A890-62FBCE9FC724Q38733415-49DDC742-3997-4D58-9B28-0179358A81B6Q38823146-F4CE1561-0FAE-45F4-BEED-65746E42CF06Q38987620-9DB506B0-12E5-4BF1-8399-C60D21938396Q39090561-A71421B9-7D49-4E05-9A64-0B903ED4CCE1Q39295799-9DF02774-4E9F-4770-986D-AAA8E679B260Q39758681-F4E3F902-7F5D-4A34-AA12-0042C37402FBQ39789571-4C81557E-6252-4F10-BEF7-0FA718F67C84Q39923158-E97F62DE-940F-4DF8-A23D-E0FBEDBDC50BQ40782006-B63521BC-D013-4A78-A085-1586DA61731FQ42488046-3BF29F79-933D-42EB-99F6-EF7687281515Q42947996-8A914E58-1DE6-46F1-A1AE-7D03D6FB21CFQ42967594-C740FC8E-4260-4752-B03D-13CE59776BDFQ43024641-4F527D6F-FED7-4572-AE6F-9BF765428AF2
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anders Fink-Jensen
@ast
Anders Fink-Jensen
@en
Anders Fink-Jensen
@es
Anders Fink-Jensen
@nl
Anders Fink-Jensen
@sl
type
label
Anders Fink-Jensen
@ast
Anders Fink-Jensen
@en
Anders Fink-Jensen
@es
Anders Fink-Jensen
@nl
Anders Fink-Jensen
@sl
prefLabel
Anders Fink-Jensen
@ast
Anders Fink-Jensen
@en
Anders Fink-Jensen
@es
Anders Fink-Jensen
@nl
Anders Fink-Jensen
@sl
P106
P1153
7004063091
P21
P31
P496
0000-0001-7143-1236